Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Medpace stock

Learn how to easily invest in Medpace stock.

Medpace Holdings Inc
+ $8.71 ( + 5.58%)

Medpace Holdings Inc is a diagnostics & research business based in the US. Medpace shares (MEDP) are listed on the NASDAQ and all prices are listed in US Dollars. Medpace employs 4,800 staff and has a trailing 12-month revenue of around $1.3 billion.

How to buy shares in Medpace

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – MEDP – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

Medpace stock price (NASDAQ: MEDP)

Use our graph to track the performance of MEDP stocks over time.

Medpace shares at a glance

Information last updated 2022-09-25.
Latest market close$156.14
52-week range$126.95 - $231.00
50-day moving average $161.45
200-day moving average $161.46
Wall St. target price$145.33
PE ratio 27.0223
Dividend yield $0 (0%)
Earnings per share (TTM) $5.38

Buy Medpace shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 7 of 7
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, ETFs, Cryptocurrency
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
Stocks, ETFs, Cryptocurrency
8%-12% of your deposit
when you sign up and deposit at least $50. T&Cs apply.
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, TN, and HI.
Stocks, ETFs, Cryptocurrency
Receive a free stock slice worth between $3–$300
when you sign up for an account and deposit at least $20.
Commission-free trading in stocks and ETFs with a social networking twist.
Stocks, Options, ETFs, Cryptocurrency
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$125 - $625
when you open and fund an account with $25,000 - $250,000+
Stocks, Options, ETFs, Cryptocurrency
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 3% interest on uninvested cash in your account with Robinhood Gold.
Stocks, Options, ETFs
Customize your trade platform or build your own Deep tools, charts and screens Analyzers to help you study before you trade

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Medpace stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Medpace price performance over time

Historical closes compared with the close of $156.14 from 2022-09-29

1 week (2022-09-23) 7.40%
1 month (2022-08-29) 0.70%
3 months (2022-06-30) 4.32%
6 months (2022-03-29) -5.78%
1 year (2021-09-30) -17.51%
2 years (2020-09-30) 39.72%
3 years (2019-09-30) 85.79%
5 years (2017-09-29) 389.47%

Is Medpace stock undervalued or overvalued?

Valuing Medpace stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Medpace's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Medpace's P/E ratio

Medpace's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 27x. In other words, Medpace shares trade at around 27x recent earnings.

That's comparable to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29).

Medpace's PEG ratio

Medpace's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.97. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Medpace's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Medpace's EBITDA

Medpace's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $254.5 million.

The EBITDA is a measure of a Medpace's overall financial performance and is widely used to measure a its profitability.

Medpace financials

Revenue TTM $1.3 billion
Operating margin TTM 18.12%
Gross profit TTM $701.3 million
Return on assets TTM 10.46%
Return on equity TTM 36.87%
Profit margin 16.27%
Book value $9.17
Market capitalisation $4.5 billion

TTM: trailing 12 months

Medpace share dividends

We're not expecting Medpace to pay a dividend over the next 12 months.

Medpace share price volatility

Over the last 12 months, Medpace's shares have ranged in value from as little as $126.945 up to $231. A popular way to gauge a stock's volatility is its "beta".

MEDP.US volatility(beta: 1.47)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Medpace's is 1.4674. This would suggest that Medpace's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Medpace overview

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, it offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The company was founded in 1992 and is based in Cincinnati, Ohio. .

Frequently asked questions

What percentage of Medpace is owned by insiders or institutions?
Currently 23.489% of Medpace shares are held by insiders and 87.839% by institutions.
How many people work for Medpace?
Latest data suggests 4,800 work at Medpace.
When does the fiscal year end for Medpace?
Medpace's fiscal year ends in December.
Where is Medpace based?
Medpace's address is: 5375 Medpace Way, Cincinnati, OH, United States, 45227
What is Medpace's ISIN number?
Medpace's international securities identification number is: US58506Q1094
What is Medpace's CUSIP number?
Medpace's Committee on Uniform Securities Identification Procedures number is: 58506Q109

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site